Light-at-night-induced circadian disruption, cancer and aging

Current Aging Science

Volumn 5, Issue 3, 2012, Pages 170-177

  Anisimov, Vladimir N ^a   Vinogradova, Irina A ^b   Panchenko, Andrei V ^a   Popovich, Irina G ^a   Zabezhinski, Mark A ^a  

^a N N PETROV RESEARCH INSTITUTE OF ONCOLOGY   (Russian Federation)

^b PETROZAVODSK STATE UNIVERSITY   (Russian Federation)

Author keywords

Aging; Cancer; Circadian rhythm; Light at night; Melatonin

Indexed keywords

1,2 DIMETHYLHYDRAZINE; MELATONIN; METHYLNITROSOUREA;

AGING; ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CANCER GROWTH; CANCER PREVENTION; CHEMICAL CARCINOGENESIS; CIRCADIAN RHYTHM; COLON CANCER; COLON CARCINOGENESIS; ESTRUS CYCLE; HOMEOSTASIS; HUMAN; ILLUMINATION; LIGHT EXPOSURE; METABOLIC SYNDROME X; NONHUMAN; PRIORITY JOURNAL; RUSSIAN FEDERATION;

AGE FACTORS; AGING; ANIMALS; ANTICARCINOGENIC AGENTS; BLINDNESS; CELL TRANSFORMATION, NEOPLASTIC; CIRCADIAN RHYTHM; FEMALE; HUMANS; LIGHT; MALE; MELATONIN; MICE; NEOPLASMS, RADIATION-INDUCED; PHOTOPERIOD; RATS; REPRODUCTION; RISK ASSESSMENT; RISK FACTORS; SLEEP DISORDERS, CIRCADIAN RHYTHM; TIME FACTORS;

EID: 84874830779     PISSN: 18746098     EISSN: 18746128     Source Type: Journal    
DOI: 10.2174/1874609811205030002     Document Type: Article

References (71)

1. Straif K, Baan R, Grosse Y, et al. Carcinogenicity of shift-work, painting, and fire-fighting. Lancet Oncol 2007; 8: 1065-6.
2. Reppert SM, Weaver DR. Coordination of circadian timing in mammals. Nature 2002; 418: 935-41.
3. Bell-Pedersen D, Cassone VM, Earnest DJ. et al. Circadian rhythms from multiple oscillators: lessons from diverse organisms. Nat Rev Genet 2005; 6: 544-56.
4. Knutsson A. Health disorders of shift workers. Occup Med 2003; 53: 103-8.
5. Ha M, Park J. Shift work and metabolic risk factors of cardiovascular disease. J Occup Health 2005; 47: 89-95.
6. Anisimov VN. Light pollution, reproductive function and cancer risk. Neuro Endocrinol Lett 2006; 27: 35-52.
7. Stevens RG. Light-at-night, circadian disruption and breast cancer: assessment of existing evidence. Int J Epidemiol 2009; 38: 963-70.
8. Parkin, DM, Bray FI, Deseva SS. Cancer burden in the year 2000. The global picture. Eur J Cancer 2001; 37: S4-S66.
9. Schernhammer ES, Laden F, Spezer FE, et al. Night-shift work and risk of colorectal cancer in the Nurses' Health Study. J Natl Cancer Inst 2003; 95: 825-8.
10. Filipski E, Levi F, Circadian disruption in experimental cancer processes. Interg Cancer Ther 2009; 8: 298-302.
11. Fu L, Pelicano H, Liu J, Huang P, Lee CC. The circadian gene Period2 plays an important role in tumor suppression and DNA damage response in vivo. Cell 2002; 111: 41-50.
12. Chen ST, Choo KB, Hou MF, Yeh KT, Kuo SJ, Chang JG. Deregulated expression of the PER1, PER2 and PER3 genes in breast cancers. Carcinogenesis 2005; 26: 1241-6.
13. Kuo SJ, Chen ST, Yeh KT, Hou MF, Chang YS, Hsu NC, Chang JG. Disturbance of circadian gene expression in breast cancer. Virchov Arch 2009; 454: 467-74.
14. Anisimov VN, Ukraintseva SV, Yashin AI. Cancer in rodents: does it tell us about cancer in humans? Nat Rev Cancer 2005; 5: 807-19.
15. Weinert D. Circadian temperature variation and ageing. Ageing Res Rev 2010; 9: 51-60.
16. Hoffmann JC. Effect of photoperiods on estrous cycle length in the rat. Endocrinology 1968; 83: 1355-7.
17. Aschheim P. Aging in the hypothalamic-hypophyseal-ovarian axis in the rat. In: Everitt AV & Burgess JA, eds. Springfield: Charles C Tomas, 1976; pp. 376-92.
18. Lazarev NI, Ird IO, Smirnova IO. 1976. Experimental Models of Endocrine Gynecological Diseases. Moscow: Meditsina.
19. Prata Lima MF, Baracat EC, Simones MJ. Effects of melatonin on the ovarian response to pinealectomy or continuous light in female rats: similarity with polycystic ovary syndrome. Braz J Med Biol Res 2004; 37: 987-95.
20. Anisimov VN. Blastomogenesis in persistent-estrous rats. Vopr Onkol 1971; 8: 67-75.
21. Klochkov DV, Beliaev DK. Effect of continuous illumination on the reproductive function in rats. Aftereffects. Ontogenez 1977; 8: 487-96.
22. Vinogradova IA, Chernova IV. Effect of light regimen on agerelated dynamics of estrous function and blood prolactin level in rats. Adv Gerontol 2006; 19: 60-5.
23. Baturin DA, Alimova IN, Anisimov VN, et al. Effect of light regime and melatonin on the development of spontaneous mammary tumors in HER-2/neu transgenic mice is related to a downregulation of HER-2/neu gene expression. Neuroendocrinol Lett 2001; 22: 439-45.
24. Anisimov VN, Baturin DA, Popovich IG, et al. Effect of exposure to light-at-night on life span and spontaneous carcinogenesis in female CBA mice. Int J Cancer 2004; 111: 475-9.
25. Baturin DA, Alimova IN., Popovich IG, et al. Effect of light deprivation on homeostasis, life span and development of spontaneous tumors in HER-2/neu transgenic mice. Vopr Onkol 2004; 50: 332-8.
26. Lin MC, Kripke DF, Parry BL, Berga SL. Night light alters menstrual cycles. Psychiatry Res 1990; 33: 135-8.
27. Chung FF, Yao CC, Wan GH. The associations between menstrual function and life style/working conditions among nurses in Taiwan. J Occup Health 2005; 47: 149-56.
28. Harlow SD, Ephross SA. Epidemiology of menstruation and its relevance to women's health. Epidemiol Rev 1995; 17: 265-86.
29. Dilman VM, Anisimov VN. Hypothalamic mechanisms of ageing and of specific age pathology - I. Sensitivity threshold of hypothalamo-pituitary complex to homeostatic stimuli in the reproductive system. Exp Gerontol 1979; 14: 161-74.
30. Wise PM, Gerhold LM, Cashion AB. 2005. Neuroendocrine modulation of menopause: evolution of our thinking. In: Hormones, Age and Cancer. Berstein LM (Ed). St.Petersburg, Nauka, pp. 94-111.
31. Boettner M, Leonhardt S, Wuttke W, Wedel T, Jarry H. Expression of estrogen receptors in the hypothalamus-pituitary-ovarian axis in middle-aged rats after re-instatement of estrus cyclicity. Biogerontology 2010; 11: 75-85.
32. Dilman VM. 1994. Development, Aging and Disease. A New Rationale for an Intervention Strategy. Chur: Harwood Acad Publ.
33. Tenkane L, Sjoblom T, Kalino T, Alikoski T, Harma M. Shift work, occupation and coronary heart disease over a 6-years of follow up in the Helsinki Heart Study. Scand. J. Work Environ. Health 1997; 23: 257-65.
34. Knutsson A, Boggild H. Shiftwork, risk factors and cardiovascular disease: review of disease mechanisms. Rev Environ Health 2000; 15: 359-72.
35. Taylor PJ, Pocock SJ. Mortality of shift and day workers 1956-68. Brit J Industr Med 1972; 29: 201-7.
36. Hansen J. Increased breast cancer risk among women who work predominantly at night. Ann Epidemiol 2001; 12: 74-7.
37. Pukkala E, Auvinen H, Wahlberg G. Incidence of cancer among Finnish arline cabin attendants, 1967-92. Br Med J 1995; 311: 649-52.
38. Reynolds P, Con, J, Layefsky M, Goldberg DE, Hurley S. Cancer incidence in California flight attendants (United States). Cancer Causes Control 2002; 13: 317-24.
39. Davis S, Kaune WT, Mirick DK, Chen C, Stevens RG. Residental magnetic fields, light-at-night, and nocturnal urinary 6-sulfatoxymelatonin concentration in women. Am J Epidemiol 2001; 154: 591-600.
40. Schernhammer ES, Laden F, Speizer FE, et al. Rotating night shifts and risk of breast cancer in women participating in the nurses' health study. J Natl Cancer Inst 2001; 93: 1563-8.
41. Schernhamme ES, Rosner B, Willett WC, Laden F, Coldiz GA, Hankinson SE. Epidemiology of urinary melatonin in women and its relation to other hormones and night work. Cancer Epidemiol Biomarkers Prev 2004; 13: 936-43.
42. Megdal SP, Kroenke CH, Laden F, Pukkala E, Schernhammer ES. Night work and breast cancer risk: a systemic review and meta-analysis. Eur J Cancer 2005; 41: 2023-32.
43. Tynes T, Hannevik M, Andersen A, Vistnes Aim Haldorsen T. Incidence of breast cancer in Norwegian female radio and telegraph operators. Cancer Causes Control 1996; 7: 197-204.
44. Rafnsson V, Tulinius H, Jonasson J, Hrafnkelsson J. Risk of breast cancer in female flight attendants: a population-based study (Iceland). Cancer Cause Control 2001; 12: 95-101.
45. Johle W. Trends in photophysiologic concept. Ann N Y Acad Sci 1964; 11: 88-104.
46. Vinogradova IA, Anisimov VN, Bukalev AV, Semenchenko AV, Zabezhinski MA. Circadian disruption induced by light-at-night accelerates aging and promotes tumorigenesis in rats. Aging (Albany, NY) 2009; 1: 855-65.
47. Vinogradova IA, Bukalev AV, Zabezhinski MA, Semenchenko AV, Anisimov VN. Effect of light regimen and melatonin on the homeostasis, life span and development of spontaneous tumors in female rats. Adv Gerontol 2007; 20: 40-7.
48. Bartsch C, Bartsch H. Effects of melatonin and constant light on the development of spontaneous endometrial carcinomas in aging BDII/Han rats appear to be exerted by modulating maturation of the reproductive system. Z Gerontol Geriatrie 1999; 32 (Suppl 2): 2-5.
49. Khaetski IK. Effect of hypothalamo-pituitary lesions induced by constant illumination on development of induced mammary tumors in rats. Vopr Exp Oncol (Kiev) 1965; 1: 87-93.
50. Hamilton T. Influence of environmental light and melatonin upon mammary tumour induction. Br J Surg 1969; 56: 764-6.
51. Kothari L. Effect of melatonin on the mammary gland morphology, DNA synthesis, hormone profiles and incidence of mammary cancer in rats. In: Gupta D, Attanasio A & Reiter RJ, eds. The Pineal Gland and Cancer. London: Brain Res Promotion. 1988; 210-9.
52. Mhatre MC, Shah PN, Juneja HS. Effect of various photoperiods on mammary morphology, DNA synthesis, and hormone profile in female rats. J Natl Cancer Inst 1984; 72: 1411-6.
53. Anisimov VN, Zhukova OV, Beniashvili D, Bilanishvili V, Menabde MZ. Light deprivation, electromagnetic fields and mammary carcinogenesis. Adv Pineal Res 1994; 7: 229-34.
54. Cos S, Mediavilla D, Martinez-Campa C, Gonzalez A, Laonso-Gonzalez C, Sanchez-Barcelo EJ. Exposure to light-at-night increases the growth of DMBA-induced mammary adenocarcinomas in rats. Cancer Lett 2006; 235: 266-71.
55. Anderson LE, Morris JE, Sasser LB, Stevens RG. Effect of constant light on DMBA-induced mammary tumorigenesis in rats. Cancer Lett 2000; 148: 121-6.
56. Travlos GS, Wilson RE, Murrell JA, Chignell CF, Boorman GA. The effect of short intermittent light exposure on the melatonin circadian rhythm and NMU-induced breast cancer in female F344/N rats. Toxicol Pathol 2001; 29: 126-36.
57. Van den Heilignerberg S, Depres-Brummer P, Barbason H, Claustrat B, Reynes M, Levi F. The tumor promoting effect of constant light exposure on diethylnitrosamine-induced hepatocarcinogenesis in rats. Life Sci 1999; 64: 2523-34.
58. Beniashvili DS, Benjamin S, Baturin DA, Anisimov VN. Effect of light/dark regimen on N-nitrosoethylurea-induced transplacental carcinogenesis in rats. Cancer Lett 2001; 163: 51-7.
59. Panchenko AV, Petritschev NN, Kvetnoi IM, Anisimov VN. Colon carcinogenesis in rats maintaned at various light regimens. Vopr Onkol 2008; 54: 332-6.
60. Kuralasov AK. Effect of dark adaptation on carcinogenesis and efficacy of treatment DMBA-induced mammary tumor. Proc. Acad. Sci. Kazakh. SSR, Ser. Biol. 4:79-82.
61. Kuralasov AK. Experimental Bases for Use of Artificial Photoregimen for Breast Cancer Treatment in Kazakhstan. Diss. Doctor Med. Sci. Moscow: All-Union Cancer Center.
62. Blask DE, Hill SM, Pelletier DB. Oncostatic sygnaling by the pineal gland and melatonin in the control of breast cancer. In: Gupta D, Attanasio A, Reiter RJ, eds. The Pineal Gland and Cancer. London: Brain Res Promotion. 1988; 221-232.
63. Anisimov VN, Zhukova OV, Labunets IF, Bartsch H, Bartsch C. The inhibitory effect of light deprivation on N-nitrosomethylureainduced carcinogenesis and on the growth of transplanted tumors in rodents: possible involvement of the pineal gland and the immune system. Exp Oncol 1995; 17: 47-54.
64. Hahn RA. Profound bilateral blindness and the incidence of breast cancer. Epidemiology 1991; 2: 108-210.
65. Feychting M, Oosterlund B, Ahlbom A. Reduced cancer incidence among the blind. Epidemiology 1998; 9: 490-4.
66. Pukkala E, Verkasalo PK, Ojamo M, Rudanko SL. Visual impairment and cancer: a population-based cohort study in Finland. Cancer Causes Control 1999; 10: 13-20.
67. Kliukiene J, Tynes T, Anderson A. Risk of breast cancer among norvegian women with visual impairment. Br J Cancer 2001; 84: 397-9.
68. Anisimov VN, Popovich IG, Zabezhinski MA, Anisimov SV, Vesnushkin GM, Vinogradova IA. Melatonin as antioxidant, geroprotector and anticarcinogen. Biochim Biophys Acta 2006: 1757: 573-89.
69. Bartsch C, Bartsch H, Peschke E. Light, melatonin and cancer: current results and future perspectives. Biol Rhythm Res 2009: 40: 17-35.
70. Blask DE. Melatonin, sleep disturbance and cancer risk. Sleep Med Rev 2009; 13: 257-64.
71. Kloog I, Haim A, Stevens RG, Portnov BA. Global co-distribution of light at night (LAN) and cancers of prostate, colon, and lung in men. Chronobiol Int 2009; 26: 108-25.